182 related articles for article (PubMed ID: 12854489)
1. [Pathology of intraductal papillary-mucinous tumor of the pancreas].
Nobukawa B; Suda K; Yamasaki S; Takase M; Fukumura Y; Shiono S
Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):439-42. PubMed ID: 12854489
[TBL] [Abstract][Full Text] [Related]
2. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
[TBL] [Abstract][Full Text] [Related]
3. [Molecular factors promoting carcinogenesis and malignant behavior of intraductal papillary mucinous tumors].
Ichikawa Y; Ueda M; Miura Y; Kunihiro S; Ishikawa T; Endo I; Sekido H; Shimada H
Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):443-6. PubMed ID: 12854490
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
[TBL] [Abstract][Full Text] [Related]
5. Intraductal papillary mucinous neoplasm.
Shi C; Hruban RH
Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
[TBL] [Abstract][Full Text] [Related]
6. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas.
Klöppel G
Hepatogastroenterology; 1998; 45(24):1981-5. PubMed ID: 9951851
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas.
Furukawa T
J Hepatobiliary Pancreat Surg; 2007; 14(3):233-7. PubMed ID: 17520197
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: the differential diagnosis from benign entities.
Kawai M; Uchiyama K; Tani M; Onishi H; Kinoshita H; Ueno M; Hama T; Yamaue H
Arch Surg; 2004 Feb; 139(2):188-92. PubMed ID: 14769579
[TBL] [Abstract][Full Text] [Related]
10. Familial intraductal papillary mucinous neoplasms of the pancreas.
Rebours V; Couvelard A; Peyroux JL; Sauvanet A; Hammel P; Ruszniewski P; Lévy P
Dig Liver Dis; 2012 May; 44(5):442-6. PubMed ID: 21824831
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
[TBL] [Abstract][Full Text] [Related]
12. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S
J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
[TBL] [Abstract][Full Text] [Related]
13. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
Wada K
J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
15. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
[TBL] [Abstract][Full Text] [Related]
16. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?
Jang JY; Kim SW; Ahn YJ; Yoon YS; Choi MG; Lee KU; Han JK; Kim WH; Lee YJ; Kim SC; Han DJ; Kim YI; Choi SH; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee KB; Kim YC; Lee KS; Kim MW; Kim HJ; Kim HJ; Park YH
Ann Surg Oncol; 2005 Feb; 12(2):124-32. PubMed ID: 15827792
[TBL] [Abstract][Full Text] [Related]
17. Problems in histological diagnosis of intraductal papillary-mucinous tumor (IPMT).
Nagasaka T; Nakashima N
Hepatogastroenterology; 2001; 48(40):972-6. PubMed ID: 11490851
[TBL] [Abstract][Full Text] [Related]
18. Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas.
Nakagohri T; Konishi M; Inoue K; Tanizawa Y; Kinoshita T
Hepatogastroenterology; 2004; 51(59):1480-3. PubMed ID: 15362782
[TBL] [Abstract][Full Text] [Related]
19. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
[TBL] [Abstract][Full Text] [Related]
20. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]